Chris Nolet - 03 Jul 2025 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Director
Signature
By: /s/ Herb Cross, as Attorney-in-Fact
Issuer symbol
JSPR
Transactions as of
03 Jul 2025
Net transactions value
$0
Form type
4
Filing time
03 Jul 2025, 16:23:04 UTC
Previous filing
20 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Nolet Chris Director C/O JASPER THERAPEUTICS, INC., 2200 BRIDGE PKWY, SUITE #102, REDWOOD CITY By: /s/ Herb Cross, as Attorney-in-Fact 03 Jul 2025 0001782814

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JSPR Stock Option (right to buy) Award $0 +7,500 $0.000000 7,500 03 Jul 2025 Voting Common Stock 7,500 $6.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted automatically pursuant to the Issuer's Non-Employee Director Compensation Policy, which provides that non-employee directors are automatically granted an option to purchase 7,500 shares on the date of each of the Issuer's annual meeting of stockholders.